To reveal potent ACE inhibitors, researchers screen various bioactive peptides from several
sources, and more attention has been given to aquatic sources. This review summarizes the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of
coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory …

Aims Transactivation of insulin-growth-factor-receptor (IGF-1R) by angiotensin-II-type-1-
receptor (AT-1R) was only demonstrated in vascular-smooth-muscle cells and has never …

The renin–angiotensin system (RAS)—a classical blood pressure regulator—largely
contributes to healthy organ development and function. Besides, RAS activation promotes …

With a high incidence of acute kidney injury among hospitalized COVID-19 patients,
considerable attention has been focussed on whether SARS-CoV-2 specifically targets …

Background: Mounting experimental evidence supports the concept that the RAAS (renin-
angiotensin-aldosterone system) is involved in the pathogenesis of intracranial aneurysm …

Background: The main mechanism of viral entry in COVID-19 infection is through the
angiotensin-converting enzyme 2 (ACE2) receptor present in the lungs. Numerous studies …

Sartans (angiotensin II receptor blockers, ARBs), drugs used in the treatment of
hypertension, play a principal role in addressing the global health challenge of …

Despite the protracted battle against coronavirus acute respiratory infection (COVID-19) and
the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Angiotensin-converting enzyme (ACE) inhibitors, which prevent the conversion of
angiotensin I to angiotensin II, are well-known for the treatments of cardiovascular diseases …